Clinical trials
Sarcoma trials in France with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 13 |
| Completed | 6 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre Leon Berard | 6 |
| Institut Bergonié | 4 |
| Institut Claudius Regaud | 3 |
| Institut du Cancer de Montpellier - Val d'Aurelle | 3 |
| Centre Oscar Lambret | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Centre Georges Francois Leclerc | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Hospices Civils de Lyon | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 27 |
| Neoplasms | 5 |
| Breast Neoplasms | 3 |
| Colonic Neoplasms | 2 |
| Esophageal Neoplasms | 2 |
| Head and Neck Neoplasms | 2 |
| Histiocytoma, Malignant Fibrous | 2 |
| Kidney Neoplasms | 2 |
| Leiomyosarcoma | 2 |
| Liposarcoma | 2 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.